We reported in January that Biden was ending President Trump’s policy providing for lower prices for insulin to Americans:
The measure, signed off on under the previous administration in December, aimed to require some 340B community health centers to deliver savings to low-income patients for insulin and epinephrine in a bid to bring down unaffordable prices.
Advertisement – story continues below
Spokespeople for the White House and the Department of Health and Human Services did not return FOX Business’ request for comment.
The rule was scheduled to go into effect in January but was frozen at that time.